ES2523663T3 - Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV - Google Patents

Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV Download PDF

Info

Publication number
ES2523663T3
ES2523663T3 ES06753441.2T ES06753441T ES2523663T3 ES 2523663 T3 ES2523663 T3 ES 2523663T3 ES 06753441 T ES06753441 T ES 06753441T ES 2523663 T3 ES2523663 T3 ES 2523663T3
Authority
ES
Spain
Prior art keywords
matrix
content
active substance
layer
absorbing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06753441.2T
Other languages
English (en)
Inventor
Thomas Langguth
Stefan Bracht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Application granted granted Critical
Publication of ES2523663T3 publication Critical patent/ES2523663T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV, cuya sucesión de capas se compone de por lo menos tres capas, comenzando esta sucesión de capas, en la posición que está apartada en la mayor distancia desde la piel, con una capa trasera (1), una matriz (2) que tiene un contenido de una sustancia activa, a base de por lo menos una capa, una lámina protectora desprendible (3) y facultativamente una capa adhesiva (4) incorporada entre la capa trasera (1) y la matriz (2) que tiene un contenido de una sustancia activa y una capa de separación (5) que sigue a la matriz (2) que tiene un contenido de una sustancia activa, estando el/los agente(s) absorbente(s) de rayos UV que se esoge(n) entre el conjunto formado por las hidroxifeniltriazinas, embebido(s) en la capa trasera (1) o en la matriz (2) que tiene un contenido de una sustancia activa, o en la capa adhesiva (4), y conteniendo un gestágeno la matriz que tiene un contenido de una sustancia activa,.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES06753441.2T 2005-05-02 2006-04-28 Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV Active ES2523663T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05009579A EP1719504A1 (de) 2005-05-02 2005-05-02 Festes transdermales therapeutisches System mit UV-Absorber
EP05009579 2005-05-02
PCT/EP2006/003959 WO2006117139A2 (de) 2005-05-02 2006-04-28 Festes transdermales therapeutisches system mit uv-absorber

Publications (1)

Publication Number Publication Date
ES2523663T3 true ES2523663T3 (es) 2014-11-28

Family

ID=34981458

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06753441.2T Active ES2523663T3 (es) 2005-05-02 2006-04-28 Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV

Country Status (26)

Country Link
EP (2) EP1719504A1 (es)
JP (2) JP5360877B2 (es)
KR (2) KR101426218B1 (es)
CN (2) CN108969507A (es)
AR (1) AR055927A1 (es)
AU (1) AU2006243442A1 (es)
BR (1) BRPI0611087A2 (es)
CA (1) CA2605112C (es)
CR (1) CR9483A (es)
CY (1) CY1115757T1 (es)
DK (1) DK1879560T3 (es)
DO (1) DOP2006000100A (es)
EA (1) EA200702344A1 (es)
ES (1) ES2523663T3 (es)
GT (1) GT200600183A (es)
IL (1) IL186945A0 (es)
MX (1) MX2007013779A (es)
NO (1) NO20076187L (es)
PE (1) PE20061414A1 (es)
PL (1) PL1879560T3 (es)
PT (1) PT1879560E (es)
SI (1) SI1879560T1 (es)
TW (1) TW200719902A (es)
UY (1) UY29511A1 (es)
WO (1) WO2006117139A2 (es)
ZA (1) ZA200710418B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1594483B1 (de) 2003-02-21 2006-07-19 Schering AG Uv-stabiles transdermales pflaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
LT2613772T (lt) * 2010-09-06 2017-03-27 Bayer Intellectual Property Gmbh Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
EP0453396B1 (de) * 1990-03-30 1995-12-13 Ciba SC Holding AG Lackzusammensetzungen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US6924410B2 (en) * 2000-03-17 2005-08-02 Hisamitsu Pharmaceutical Co., Ltd. Ultraviolet-screening patch
EP1452173A1 (de) * 2003-02-25 2004-09-01 Schering AG UV-stabiles transdermales Pflaster
EP1594483B1 (de) 2003-02-21 2006-07-19 Schering AG Uv-stabiles transdermales pflaster
EP1664128B1 (en) * 2003-09-11 2009-01-21 Ciba Holding Inc. Water based concentrated product forms of light stabilizers made by a heterophase polymerization technique

Also Published As

Publication number Publication date
DOP2006000100A (es) 2007-01-31
PT1879560E (pt) 2014-11-19
JP5360877B2 (ja) 2013-12-04
SI1879560T1 (sl) 2015-01-30
TW200719902A (en) 2007-06-01
CN108969507A (zh) 2018-12-11
WO2006117139A2 (de) 2006-11-09
KR20130099203A (ko) 2013-09-05
CY1115757T1 (el) 2017-01-25
EP1879560B1 (de) 2014-08-27
AR055927A1 (es) 2007-09-12
KR101351161B1 (ko) 2014-01-14
JP2008540352A (ja) 2008-11-20
EA200702344A1 (ru) 2008-12-30
AU2006243442A1 (en) 2006-11-09
CA2605112C (en) 2013-11-05
EP1879560A2 (de) 2008-01-23
KR20080003854A (ko) 2008-01-08
DK1879560T3 (en) 2014-11-24
JP2013177451A (ja) 2013-09-09
WO2006117139A3 (de) 2007-04-19
CA2605112A1 (en) 2006-11-09
CN101171001A (zh) 2008-04-30
KR101426218B1 (ko) 2014-08-05
BRPI0611087A2 (pt) 2010-08-03
NO20076187L (no) 2007-11-30
MX2007013779A (es) 2008-01-22
PL1879560T3 (pl) 2015-02-27
UY29511A1 (es) 2006-08-31
GT200600183A (es) 2007-01-03
ZA200710418B (en) 2009-08-26
IL186945A0 (en) 2008-02-09
EP1719504A1 (de) 2006-11-08
CR9483A (es) 2008-01-21
PE20061414A1 (es) 2007-01-26

Similar Documents

Publication Publication Date Title
AR043248A1 (es) Sistema terapeutico transdermico estable a los rayos uv
ES2543977T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
AR097045A2 (es) Sistema terapéutico transdérmico
ES2524696T3 (es) Vendaje del tejido de la mucosa y método de uso
AR062772A1 (es) Aposito de pelicula delgada
AR054300A1 (es) Aparato y sistema de microproyeccion con escaso potencial infeccioso
ATE369825T1 (de) Wundauflage
DE50103257D1 (de) Absorptionsmittel und kanalbildner enthaltende wirkstoffundurchlässige deckschicht oder abziehbare schutzschicht eines transdermalen therapeutischen systems
ES2523663T3 (es) Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV
AR009516A1 (es) Un dispositivo de parche de matriz adhesiva sensible a la presion, un metodo para preparar dicho dispositivo y un metodo para emplear dichodispositivo en el suministro transdermico de una droga.
CO6341593A2 (es) Estructura plastica absorbente de oxigeno
AR050621A1 (es) Sistema terapeutico transdermal con una capa adherente procedimiento para el siliconado de una capa de respaldo y empleo de la capa de respaldo
ES2529662T3 (es) Parche adhesivo médico
ES2525760T3 (es) Artículo o componente de naturaleza médica y técnica para adherir un artículo médico o parte del mismo a la piel, provisto de una capa de protección desprendible
AR070031A1 (es) Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas
AR054012A1 (es) Sistema terapeutico transdermico para la adminstracion de analgesicos
AR025390A1 (es) Sistema terapeutico que contiene un principio activo para su aplicacion sobre la piel, con un minimo de dos capas que contengan polimeros
AR058843A1 (es) Panel de barrera
BR112019007325A2 (pt) sistema terapêutico tópico de duas camadas
BR0313092A (pt) Sistema de liberação transdérmica aperfeiçoado
PT1284718E (pt) Sistema terapeutico transdermal oclusivo com uma camada de reforco nao oclusiva
AR039137A1 (es) Unidad coherente de sistemas terapeuticos transdermicos separables
ES2063172T3 (es) Sistema terapeutico superficial con una sustancia activa antineoplasica, en especial 5-fluoruracilo.
CL2004000884A1 (es) Composicion farmaceutica en forma de hidrogel que contiene un diester de acido carbonico, un alquilalcohol c2-c4, por lo menos una sustancia activa y una matriz de polimero; uso en el tratamiento de carencias esteroidales.
CO6120155A1 (es) Pastilla antihumedad ambientadora